Brief: Medincell Publishes Ivermectin Safety Expert Analysis
March 5 (Reuters) - Medincell SA MEDCL.PA :
* COVID-19: MEDINCELL PUBLISHES AN EXTENSIVE IVERMECTIN
SAFETY
EXPERT ANALYSIS
* NO SAFETY CONCERN IS ANTICIPATED THAT WOULD PREVENT HEALTH
AUTHORITIES FROM ASSESSING USE OF IVERMECTIN AGAINST COVID-19 AS
A NEW INDICATION
Source text for Eikon: ID:nBw1x0ckna
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))